We still have to face restrictions due to the COVID-19 pandemic in some parts of the world within a very changing global environment. In this sense, the need for a versatile interaction model that could be tailored to current contexts and, in turn, allows the participation of those excluded regions becomes evident.

The treatment of Prostate Cancer is a very challenging area for the Oncologists and the competitive landscape for all Pharma Companies working in this market.

Find a digital solution that complements face-to-face meetings to achieve high-quality, interactive, multichannel training. This way, the learning process is facilitated and discussions are improved while maintaining interaction with the HCPs for longer. Consequently, the “new normal” looks like a hybrid model.